1. Home
  2. INDP vs WNW Comparison

INDP vs WNW Comparison

Compare INDP & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • WNW
  • Stock Information
  • Founded
  • INDP 2000
  • WNW 2015
  • Country
  • INDP United States
  • WNW China
  • Employees
  • INDP N/A
  • WNW N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • INDP Health Care
  • WNW Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • WNW Nasdaq
  • Market Cap
  • INDP 7.4M
  • WNW 6.9M
  • IPO Year
  • INDP N/A
  • WNW 2020
  • Fundamental
  • Price
  • INDP $0.45
  • WNW $1.80
  • Analyst Decision
  • INDP Strong Buy
  • WNW
  • Analyst Count
  • INDP 2
  • WNW 0
  • Target Price
  • INDP $8.50
  • WNW N/A
  • AVG Volume (30 Days)
  • INDP 43.0K
  • WNW 6.6M
  • Earning Date
  • INDP 05-14-2025
  • WNW 07-07-2025
  • Dividend Yield
  • INDP N/A
  • WNW N/A
  • EPS Growth
  • INDP N/A
  • WNW N/A
  • EPS
  • INDP N/A
  • WNW 0.16
  • Revenue
  • INDP N/A
  • WNW $158,485.00
  • Revenue This Year
  • INDP N/A
  • WNW N/A
  • Revenue Next Year
  • INDP N/A
  • WNW N/A
  • P/E Ratio
  • INDP N/A
  • WNW $11.56
  • Revenue Growth
  • INDP N/A
  • WNW N/A
  • 52 Week Low
  • INDP $0.43
  • WNW $0.95
  • 52 Week High
  • INDP $3.10
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.18
  • WNW 42.72
  • Support Level
  • INDP $0.36
  • WNW $1.72
  • Resistance Level
  • INDP $0.48
  • WNW $1.98
  • Average True Range (ATR)
  • INDP 0.05
  • WNW 0.24
  • MACD
  • INDP 0.01
  • WNW 0.02
  • Stochastic Oscillator
  • INDP 59.80
  • WNW 8.12

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.

Share on Social Networks: